Literature DB >> 27077134

Carbohydrate-conjugated fluorescent silica nanoprobes for selective detection of galectin-1 and prostate cancer cells.

Ke Jiang1, Xin Wang1, Hao Geng2, Tomasz M Beer2, David Z Qian2, Olof Ramström3, Mingdi Yan4.   

Abstract

Carbohydrate-conjugated fluorescent silica nanoprobes were prepared and used as a platform for galectin-1 and prostate cancer cell detection. The nanoparticles were efficiently conjugated using native, unprotected carbohydrate structures following a photochemical approach, resulting in lactose- and cellobiose-conjugated probes, respectively. The probes were used to challenge binding to galectin-1, an overexpressed galactose-selective lectin at prostate cancer cell surfaces, and the results show that lactose-conjugated nanoprobes exhibit differential binding behavior with prostate cancer cells and normal prostate cells. In particular, lactose-conjugated fluorescent silica nanoparticles showed specific binding to PC3 cells pre-treated with a reducing agent. The results indicate that galectin-1 expression and galectin-1-selective nanoparticles are potentially useful for sensitive and selective detection of prostate cancer.

Entities:  

Keywords:  Carbohydrate; Fluorescence; Galectin; Prostate cancer; Silica nanoparticle

Year:  2015        PMID: 27077134      PMCID: PMC4827262     

Source DB:  PubMed          Journal:  Sci Lett J


  30 in total

Review 1.  Quantum dot bioconjugates for imaging, labelling and sensing.

Authors:  Igor L Medintz; H Tetsuo Uyeda; Ellen R Goldman; Hedi Mattoussi
Journal:  Nat Mater       Date:  2005-06       Impact factor: 43.841

2.  Ultrasensitive DNA detection using highly fluorescent bioconjugated nanoparticles.

Authors:  Xiaojun Zhao; Rovelyn Tapec-Dytioco; Weihong Tan
Journal:  J Am Chem Soc       Date:  2003-09-24       Impact factor: 15.419

3.  Conjugation of biomolecules with luminophore-doped silica nanoparticles for photostable biomarkers.

Authors:  S Santra; P Zhang; K Wang; R Tapec; W Tan
Journal:  Anal Chem       Date:  2001-10-15       Impact factor: 6.986

4.  Aptamer-modified gold nanoparticles for colorimetric determination of platelet-derived growth factors and their receptors.

Authors:  Chih-Ching Huang; Yu-Fen Huang; Zehui Cao; Weihong Tan; Huan-Tsung Chang
Journal:  Anal Chem       Date:  2005-09-01       Impact factor: 6.986

5.  Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer.

Authors:  J Ellerhorst; P Troncoso; X C Xu; J Lee; R Lotan
Journal:  Urol Res       Date:  1999-10

6.  Quantitative and reversible lectin-induced association of gold nanoparticles modified with alpha-lactosyl-omega-mercapto-poly(ethylene glycol).

Authors:  H Otsuka; Y Akiyama; Y Nagasaki; K Kataoka
Journal:  J Am Chem Soc       Date:  2001-08-29       Impact factor: 15.419

7.  In vivo cancer targeting and imaging with semiconductor quantum dots.

Authors:  Xiaohu Gao; Yuanyuan Cui; Richard M Levenson; Leland W K Chung; Shuming Nie
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

8.  Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding.

Authors:  María F López-Lucendo; Dolores Solís; Sabine André; Jun Hirabayashi; Ken-ichi Kasai; Herbert Kaltner; Hans-Joachim Gabius; Antonio Romero
Journal:  J Mol Biol       Date:  2004-10-29       Impact factor: 5.469

9.  Surface adsorption and transfer of organomercaptans to colloidal gold and direct identification by matrix assisted laser desorption/ionization mass spectrometry.

Authors:  John S Kirk; Paul W Bohn
Journal:  J Am Chem Soc       Date:  2004-05-12       Impact factor: 15.419

Review 10.  Galectin-1 as a potential cancer target.

Authors:  G A Rabinovich
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

View more
  1 in total

1.  Galectin-1 knockdown improves drug sensitivity of breast cancer by reducing P-glycoprotein expression through inhibiting the Raf-1/AP-1 signaling pathway.

Authors:  Fang Wang; Pengwei Lv; Yuanting Gu; Lin Li; Xin Ge; Guangcheng Guo
Journal:  Oncotarget       Date:  2017-04-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.